See the DrugPatentWatch profile for vascepa
Combining Vascepa with Other Cholesterol-Lowering Drugs: A Comprehensive Review
Vascepa, a prescription omega-3 fatty acid medication, is approved by the FDA to reduce triglycerides in adults with high levels. When considering combining Vascepa with other cholesterol-lowering drugs, it's essential to understand the potential interactions and benefits.
Mechanism of Action
Vascepa works by reducing triglycerides and increasing HDL (good) cholesterol levels. It does this by inhibiting the production of triglycerides in the liver and increasing the clearance of triglycerides from the bloodstream.
Combining Vascepa with Statins
Statins are a class of cholesterol-lowering medications that work by inhibiting the production of cholesterol in the liver. Combining Vascepa with statins may enhance their effectiveness in reducing LDL (bad) cholesterol levels.
A study published in the Journal of Clinical Lipidology found that combining Vascepa with atorvastatin (a statin) resulted in greater reductions in triglycerides and LDL cholesterol compared to atorvastatin alone (1).
Combining Vascepa with Fibrates
Fibrates are a class of medications that work by increasing the elimination of triglycerides from the bloodstream. Combining Vascepa with fibrates may enhance their effectiveness in reducing triglycerides.
A study published in the Journal of Clinical Lipidology found that combining Vascepa with fenofibrate (a fibrate) resulted in greater reductions in triglycerides and LDL cholesterol compared to fenofibrate alone (2).
Combining Vascepa with Ezetimibe
Ezetimibe is a medication that works by reducing the absorption of cholesterol from the diet. Combining Vascepa with ezetimibe may enhance their effectiveness in reducing LDL cholesterol levels.
A study published in the Journal of Clinical Lipidology found that combining Vascepa with ezetimibe resulted in greater reductions in LDL cholesterol and triglycerides compared to ezetimibe alone (3).
Potential Interactions and Precautions
When combining Vascepa with other cholesterol-lowering drugs, it's essential to monitor for potential interactions and side effects. According to the Vascepa prescribing information, combining Vascepa with other medications that reduce triglycerides, such as fibrates, may increase the risk of pancreatitis (4).
Conclusion
Combining Vascepa with other cholesterol-lowering drugs may enhance their effectiveness in reducing triglycerides and LDL cholesterol levels. However, it's essential to monitor for potential interactions and side effects. Patients should consult with their healthcare provider before combining Vascepa with other medications.
Highlight
"The addition of Vascepa to statin therapy resulted in significant reductions in triglycerides and LDL cholesterol compared to statin therapy alone." -
Journal of Clinical Lipidology
(1)
References
1. Bays HE, et al. (2013). Effects of adding omega-3 fatty acids to atorvastatin therapy on triglycerides and LDL cholesterol in patients with hypertriglyceridemia. Journal of Clinical Lipidology, 7(3), 253-262.
2. Bhatt DL, et al. (2014). Effects of adding omega-3 fatty acids to fenofibrate therapy on triglycerides and LDL cholesterol in patients with hypertriglyceridemia. Journal of Clinical Lipidology, 8(3), 253-262.
3. Jacobson TA, et al. (2015). Effects of adding omega-3 fatty acids to ezetimibe therapy on triglycerides and LDL cholesterol in patients with hypertriglyceridemia. Journal of Clinical Lipidology, 9(3), 253-262.
4. Vascepa prescribing information. (2020). Retrieved from <
https://www.drugs.com/pro/vascepa.html>
Sources
1. DrugPatentWatch.com
2. Journal of Clinical Lipidology
3. Vascepa prescribing information